In the past one week, the stock of the pharmaceutical company has rallied 14 per cent as compared to 0.16 per cent decline in ...

Laurus Labs' stock, down over 10% from its 52-week high, shows signs of bottoming out. Analysts suggest a buying opportunity ...

Sumit Gupta, AVP Research at Centrum said that Sun Pharma is likely to report good growth, led by its specialty segment with ...

In the period between January and September, the Indian pharmaceutical market grew by an average of 7.6%, but volume growth ...

Trends in gene therapy approvals in recent years are rapidly shaping the future of manufacturing capabilities in the ...

While supply chain diversification and the US Biosecure Act can help Divi's target the $800 million revenue opportunity from ...

Lenacapavir is a long-acting injectable drug that has proven 100 per cent successful in clinical tests and subsequent human ...

Gireesh Babu, New Delhi Monday, October 14, 2024, 08:00 Hrs [IST] ...

The Bayer Co.Lab Shanghai located at Shanghai Innovation (SH-INNO) Park in Pudong's Zhangjiang area joins its global network ...

AM(IST)on Monday in an upbeat market. Ipca Laboratories Ltd.(up 1.67 per cent), Glenmark Pharmaceuticals Ltd.(up 0.75 per ...

Karnataka woos US investors in pharma & biotechnology sectors to invest in KWIN City: Nandita Vijayasimha, Bengaluru Monday, October 14, 2024, 08:00 Hrs [IST] Karnataka is activel ...

The future of the weight loss market might not revolve around GLP-1 drugs.